Improvement of Endothelial Dysfunction of Berberine in Atherosclerotic Mice and Mechanism Exploring through TMT-Based Proteomics
Open Access
- 1 June 2020
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-22
Abstract
Atherosclerosis is a multifactorial vascular disease triggered by disordered lipid metabolism, characterized by chronic inflammatory injury, and initiated by endothelial dysfunction. Berberine is the main active alkaloid of the herbal medicineCoptidis Rhizoma(Huanglian). Notably, berberine has been shown to have beneficial effects against atherosclerosis. However, the mechanisms of berberine in preventing atherosclerosis are still unclear. This study is aimed at investigating the effects and mechanisms of berberine in protecting the aorta and ameliorating atherosclerosis in apolipoprotein E-deficient (ApoE-/-) mice. Here, we demonstrated that berberine reduced serum lipid levels, antagonized hepatic lipid accumulation, improved intima-media thickening, and alleviated atherosclerotic lesions in ApoE-/-mice fed a western-type diet for 12 weeks. Meanwhile, berberine reduced aortic reactive oxygen species (ROS) generation and reduced the serum levels of malondialdehyde (MDA), oxidized low-density lipoprotein (ox-LDL), and interleukin-6 (IL-6). In aortic ring assay, berberine restored aortic endothelium-dependent vasodilatation in vivo and in vitro. Furthermore, 4,956 proteins were identified by proteomic analysis, and 199 differentially expressed proteins regulated by berberine were found to be involved in many biological pathways, such as mitochondrial dysfunction, fatty acidβ-oxidation I, and FXR/RXR activation. Summarily, these data suggested that berberine ameliorates endothelial dysfunction and protects against atherosclerosis, and thus may be a promising therapeutic candidate for atherosclerosis.Keywords
Funding Information
- National Natural Science Foundation of China (81630106, 81873104, 2018YFC1704500)
- National Natural Science Foundation of China (81630106, 81873104, 2018YFC1704500)
- National key research and development program (81630106, 81873104, 2018YFC1704500)
This publication has 60 references indexed in Scilit:
- Effects of Shenfu Injection and Its Main Components on the Contraction of Isolated Rat Thoracic Aortic RingsPLOS ONE, 2013
- Immunity, atherosclerosis and cardiovascular diseaseBMC Medicine, 2013
- Diverse Roles of Macrophages in Atherosclerosis: From Inflammatory Biology to Biomarker DiscoveryMediators of Inflammation, 2012
- Activation of AMP-Activated Protein Kinase Is Required for Berberine-Induced Reduction of Atherosclerosis in Mice: The Role of Uncoupling Protein 2PLOS ONE, 2011
- Berberine acutely activates the glucose transport activity of GLUT1Biochimie, 2011
- Daily administration of the TP receptor antagonist terutroban improved endothelial function in high‐cardiovascular‐risk patients with atherosclerosisBritish Journal of Clinical Pharmacology, 2011
- MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitroProceedings of the National Academy of Sciences, 2010
- Mitochondrial Membrane Permeabilization in Cell DeathPhysiological Reviews, 2007
- Endothelial cells injured by oxidized low density lipoproteinAmerican Journal of Hematology, 1995
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976